201 related articles for article (PubMed ID: 11290594)
1. Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen.
Seandel M; Noack-Kunnmann K; Zhu D; Aimes RT; Quigley JP
Blood; 2001 Apr; 97(8):2323-32. PubMed ID: 11290594
[TBL] [Abstract][Full Text] [Related]
2. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.
Collen A; Hanemaaijer R; Lupu F; Quax PH; van Lent N; Grimbergen J; Peters E; Koolwijk P; van Hinsbergh VW
Blood; 2003 Mar; 101(5):1810-7. PubMed ID: 12393408
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
Anand-Apte B; Pepper MS; Voest E; Montesano R; Olsen B; Murphy G; Apte SS; Zetter B
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):817-23. PubMed ID: 9112976
[TBL] [Abstract][Full Text] [Related]
4. Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3).
Zijlstra A; Aimes RT; Zhu D; Regazzoni K; Kupriyanova T; Seandel M; Deryugina EI; Quigley JP
J Biol Chem; 2004 Jun; 279(26):27633-45. PubMed ID: 15066996
[TBL] [Abstract][Full Text] [Related]
5. Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells.
Abe M; Inoue D; Matsunaga K; Ohizumi Y; Ueda H; Asano T; Murakami M; Sato Y
J Cell Physiol; 2002 Jan; 190(1):109-16. PubMed ID: 11807817
[TBL] [Abstract][Full Text] [Related]
6. Human neuroblastoma cells produce extracellular matrix-degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo.
Ribatti D; Alessandri G; Vacca A; Iurlaro M; Ponzoni M
Int J Cancer; 1998 Jul; 77(3):449-54. PubMed ID: 9663609
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
Wang H; Keiser JA
Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic activity of the purine analog 6-thioguanine.
Presta M; Belleri M; Vacca A; Ribatti D
Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690
[TBL] [Abstract][Full Text] [Related]
9. Suppression of human microvascular endothelial cell invasion and morphogenesis with synthetic matrixin inhibitors. Targeting angiogenesis with MMP inhibitors.
Jia MC; Schwartz MA; Sang QA
Adv Exp Med Biol; 2000; 476():181-94. PubMed ID: 10949665
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro.
Lamoreaux WJ; Fitzgerald ME; Reiner A; Hasty KA; Charles ST
Microvasc Res; 1998 Jan; 55(1):29-42. PubMed ID: 9473407
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane.
Wilting J; Christ B; Bokeloh M; Weich HA
Cell Tissue Res; 1993 Oct; 274(1):163-72. PubMed ID: 7694800
[TBL] [Abstract][Full Text] [Related]
12. VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane.
Wilting J; Birkenhäger R; Eichmann A; Kurz H; Martiny-Baron G; Marmé D; McCarthy JE; Christ B; Weich HA
Dev Biol; 1996 May; 176(1):76-85. PubMed ID: 8654896
[TBL] [Abstract][Full Text] [Related]
13. Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis.
Ribatti D; Nico B; Morbidelli L; Donnini S; Ziche M; Vacca A; Roncali L; Presta M
J Vasc Res; 2001; 38(4):389-97. PubMed ID: 11455210
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor fails to acutely modulate endothelial permeability during early angiogenesis in the chick chorioallantoic membrane.
DeFouw LM; DeFouw DO
Microvasc Res; 2000 Nov; 60(3):212-21. PubMed ID: 11078637
[TBL] [Abstract][Full Text] [Related]
15. Opioid growth factor modulates angiogenesis.
Blebea J; Mazo JE; Kihara TK; Vu JH; McLaughlin PJ; Atnip RG; Zagon IS
J Vasc Surg; 2000 Aug; 32(2):364-73. PubMed ID: 10917997
[TBL] [Abstract][Full Text] [Related]
16. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes.
Bråkenhielm E; Cao R; Cao Y
FASEB J; 2001 Aug; 15(10):1798-800. PubMed ID: 11481234
[No Abstract] [Full Text] [Related]
17. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1.
Liu J; Razani B; Tang S; Terman BI; Ware JA; Lisanti MP
J Biol Chem; 1999 May; 274(22):15781-5. PubMed ID: 10336480
[TBL] [Abstract][Full Text] [Related]
18. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.
Vacca A; Ribatti D; Iurlaro M; Albini A; Minischetti M; Bussolino F; Pellegrino A; Ria R; Rusnati M; Presta M; Vincenti V; Persico MG; Dammacco F
Int J Clin Lab Res; 1998; 28(1):55-68. PubMed ID: 9594364
[TBL] [Abstract][Full Text] [Related]
19. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin.
Sasaki T; Larsson H; Kreuger J; Salmivirta M; Claesson-Welsh L; Lindahl U; Hohenester E; Timpl R
EMBO J; 1999 Nov; 18(22):6240-8. PubMed ID: 10562536
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.
Salcedo R; Wasserman K; Young HA; Grimm MC; Howard OM; Anver MR; Kleinman HK; Murphy WJ; Oppenheim JJ
Am J Pathol; 1999 Apr; 154(4):1125-35. PubMed ID: 10233851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
